Maxim Group resumed coverage on Heat Biologics with a new price target
$HTBX
Biotechnology: Pharmaceutical Preparations
Health Care
Maxim Group resumed coverage of Heat Biologics with a rating of Buy and set a new price target of $14.00
Save time and jump to the most important pieces.